Adipocyte - breast, donor1.CNhs11051.11376-118A8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2.CNhs11969.11327-117E4 | 437.62 | 86.71 | 56.09 | 12.42 | 6.42 |
Adipocyte - omental, donor1.CNhs11054.11473-119C6 | 587.64 | 100.22 | 61.03 | 20.44 | 6.91 |
Adipocyte - omental, donor2.CNhs12067.11474-119C7 | 613.45 | 64.05 | 51.04 | 24.02 | 3.00 |
Adipocyte - omental, donor3.CNhs12068.11475-119C8 | 617.25 | 75.09 | 33.08 | 19.67 | 5.36 |
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9 | 659.49 | 96.83 | 39.26 | 29.66 | 3.49 |
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8 | 415.41 | 65.86 | 45.59 | 7.60 | 5.07 |
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4 | 421.99 | 90.34 | 42.96 | 17.69 | 7.58 |
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4 | 339.28 | 57.72 | 59.03 | 21.42 | 4.70 |
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7 | 158.01 | 60.45 | 20.89 | 14.25 | 4.42 |
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6 | 66.29 | 32.10 | 1.40 | 6.28 | 1.40 |
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3 | 154.00 | 58.98 | 19.22 | 13.11 | 3.93 |
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2 | 182.53 | 40.09 | 24.53 | 11.08 | 3.43 |
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6 | 611.65 | 116.22 | 87.75 | 24.75 | 5.57 |
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5 | 553.43 | 90.47 | 40.76 | 17.23 | 7.62 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5 | 613.16 | 67.23 | 34.96 | 18.15 | 2.69 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4 | 546.04 | 75.34 | 38.57 | 13.26 | 3.01 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6 | 557.96 | 75.22 | 52.58 | 11.68 | 5.11 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5 | 583.08 | 78.07 | 43.91 | 18.05 | 2.93 |
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6 | 201.67 | 56.39 | 29.55 | 18.22 | 3.45 |
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5 | 88.94 | 38.76 | 11.63 | 12.85 | 2.24 |
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5 | 94.66 | 25.70 | 21.31 | 13.17 | 1.88 |
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2 | 399.01 | 123.08 | 58.68 | 24.33 | 8.87 |
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2 | 285.11 | 122.09 | 45.03 | 15.60 | 8.08 |
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6 | 259.12 | 119.64 | 48.08 | 13.43 | 8.79 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2 | 195.92 | 108.81 | 34.00 | 8.63 | 5.73 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3 | 224.71 | 115.84 | 34.97 | 7.88 | 6.98 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4 | 221.18 | 114.21 | 34.08 | 10.70 | 6.53 |
Basophils, donor1.CNhs12546.12241-129G9 | 183.31 | 252.15 | 36.19 | 12.59 | 14.55 |
Basophils, donor2.CNhs12563.12242-129H1 | 272.90 | 265.23 | 52.97 | 15.74 | 16.89 |
Basophils, donor3.CNhs12575.12243-129H2 | 166.43 | 177.11 | 34.68 | 8.82 | 14.55 |
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4 | 345.70 | 90.10 | 18.39 | 9.19 | 2.76 |
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8 | 170.78 | 71.39 | 9.64 | 4.82 | 5.12 |
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3 | 198.19 | 80.98 | 24.40 | 17.01 | 8.50 |
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8 | 216.06 | 121.86 | 13.63 | 3.95 | 9.14 |
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8 | 266.28 | 83.45 | 18.91 | 6.40 | 4.83 |
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1 | 335.29 | 134.18 | 40.22 | 7.05 | 5.58 |
CD14+ Monocytes, donor1.CNhs10852.11224-116B9 | 235.45 | 251.51 | 38.23 | 5.54 | 23.27 |
CD14+ Monocytes, donor2.CNhs11954.11305-117B9 | 182.09 | 248.88 | 41.71 | 10.83 | 14.04 |
CD14+ Monocytes, donor3.CNhs11997.11381-118B4 | 181.86 | 205.29 | 30.38 | 6.51 | 14.97 |
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5 | 222.80 | 100.99 | 34.26 | 9.63 | 4.25 |
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5 | 221.87 | 109.15 | 33.04 | 9.39 | 6.15 |
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9 | 216.11 | 97.36 | 30.14 | 6.18 | 4.89 |
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9 | 152.52 | 151.94 | 22.83 | 6.11 | 8.29 |
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1 | 154.55 | 188.56 | 21.16 | 6.42 | 10.96 |
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2 | 137.55 | 154.77 | 20.13 | 8.73 | 6.55 |
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6 | 173.16 | 230.10 | 23.71 | 5.81 | 11.16 |
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7 | 173.10 | 273.02 | 20.56 | 6.99 | 9.05 |
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8 | 186.13 | 282.45 | 20.44 | 6.81 | 17.96 |
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6 | 212.32 | 284.53 | 23.30 | 7.48 | 16.40 |
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7 | 166.76 | 286.64 | 18.70 | 9.22 | 13.58 |
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8 | 228.44 | 406.75 | 38.78 | 11.35 | 16.08 |
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5 | 231.67 | 340.26 | 25.51 | 6.89 | 22.41 |
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6 | 197.52 | 359.53 | 30.98 | 10.33 | 18.07 |
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7 | 249.18 | 369.71 | 14.90 | 14.90 | 24.38 |
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4 | 174.50 | 214.03 | 27.30 | 8.28 | 13.74 |
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5 | 193.22 | 249.16 | 19.38 | 7.91 | 11.46 |
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6 | 250.57 | 288.32 | 33.26 | 9.21 | 14.38 |
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1 | 220.69 | 314.35 | 24.49 | 7.04 | 14.08 |
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2 | 219.84 | 453.15 | 29.85 | 7.06 | 26.32 |
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3 | 233.36 | 359.95 | 24.29 | 7.03 | 14.70 |
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7 | 148.76 | 219.35 | 22.76 | 5.61 | 13.52 |
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8 | 160.17 | 225.59 | 22.54 | 10.17 | 9.57 |
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9 | 135.97 | 251.05 | 17.90 | 11.08 | 10.23 |
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3 | 209.82 | 325.32 | 28.73 | 6.67 | 14.22 |
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4 | 194.61 | 411.35 | 17.02 | 5.67 | 22.13 |
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5 | 206.15 | 376.81 | 18.68 | 9.97 | 16.19 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8 | 194.72 | 262.05 | 27.39 | 8.04 | 18.84 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9 | 178.87 | 282.64 | 28.16 | 11.47 | 15.12 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1 | 217.19 | 356.19 | 39.09 | 10.64 | 11.08 |
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2 | 185.25 | 287.56 | 24.82 | 6.05 | 13.92 |
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3 | 229.07 | 545.42 | 34.99 | 7.00 | 24.31 |
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4 | 258.55 | 489.88 | 28.80 | 8.54 | 25.63 |
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7 | 245.27 | 187.17 | 73.73 | 12.04 | 7.61 |
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1 | 230.46 | 154.56 | 47.41 | 14.24 | 3.83 |
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4 | 302.75 | 164.37 | 59.96 | 14.26 | 4.82 |
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6 | 191.74 | 160.41 | 46.39 | 10.56 | 4.27 |
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8 | 201.99 | 163.99 | 40.55 | 9.46 | 4.96 |
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2 | 162.82 | 190.46 | 44.20 | 8.84 | 5.46 |
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8 | 300.69 | 130.82 | 76.95 | 18.81 | 5.42 |
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9 | 251.83 | 145.21 | 63.45 | 13.13 | 4.58 |
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3 | 262.12 | 162.75 | 64.66 | 17.35 | 4.38 |
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2 | 408.31 | 146.08 | 24.64 | 1.76 | 3.52 |
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7 | 327.14 | 126.16 | 31.13 | 6.01 | 4.92 |
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3 | 405.62 | 129.87 | 36.47 | 5.34 | 4.45 |
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9 | 266.28 | 116.92 | 29.87 | 4.27 | 8.11 |
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5 | 310.31 | 126.93 | 40.04 | 6.41 | 8.81 |
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8 | 359.80 | 117.25 | 27.01 | 2.30 | 5.17 |
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4 | 354.98 | 117.67 | 26.44 | 9.92 | 4.63 |
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9 | 393.07 | 122.12 | 25.76 | 3.82 | 3.82 |
CD19+ B Cells, donor1.CNhs12343.11544-120B5 | 268.10 | 181.58 | 20.49 | 2.28 | 7.40 |
CD19+ B Cells, donor2.CNhs12352.11624-122B4 | 265.43 | 207.29 | 37.00 | 5.87 | 14.68 |
CD19+ B Cells, donor3.CNhs12354.11705-123B4 | 257.27 | 196.87 | 35.93 | 5.35 | 9.17 |
CD34+ Progenitors, donor1.CNhs13227.11545-120B6 | 412.37 | 227.33 | 42.29 | 7.93 | 13.22 |
CD34+ Progenitors, donor2.CNhs12205.11625-122B5 | 476.43 | 263.44 | 30.27 | 6.17 | 18.50 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2 | 290.78 | 120.37 | 26.34 | 9.48 | 3.95 |
CD4+ T Cells, donor1.CNhs10853.11225-116C1 | 329.49 | 170.74 | 31.47 | 5.70 | 13.57 |
CD4+ T Cells, donor2.CNhs11955.11306-117C1 | 314.41 | 168.21 | 43.62 | 5.50 | 10.22 |
CD4+ T Cells, donor3.CNhs11998.11382-118B5 | 304.91 | 172.50 | 31.46 | 7.20 | 10.90 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2 | 214.50 | 111.51 | 30.76 | 8.36 | 2.34 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7 | 367.97 | 121.57 | 32.27 | 7.50 | 6.52 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5 | 419.95 | 107.47 | 41.66 | 5.21 | 4.26 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8 | 348.74 | 126.64 | 38.97 | 9.74 | 1.95 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3 | 230.29 | 126.45 | 35.65 | 8.36 | 3.23 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9 | 329.96 | 142.88 | 37.71 | 8.54 | 4.42 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6 | 315.91 | 155.30 | 40.98 | 10.86 | 5.10 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9 | 265.66 | 168.44 | 34.66 | 8.12 | 6.77 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8 | 219.04 | 95.94 | 24.47 | 5.76 | 5.25 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3 | 221.88 | 104.44 | 32.77 | 6.24 | 5.72 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5 | 249.62 | 81.89 | 27.63 | 5.10 | 3.12 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9 | 230.20 | 80.69 | 28.74 | 5.53 | 0.83 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9 | 210.11 | 121.72 | 24.63 | 6.67 | 1.45 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2 | 294.50 | 119.52 | 30.10 | 4.30 | 3.71 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4 | 321.58 | 117.72 | 24.35 | 4.28 | 2.41 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7 | 307.33 | 88.86 | 25.09 | 6.27 | 1.05 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1 | 191.04 | 108.89 | 28.33 | 7.93 | 3.29 |
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4 | 360.23 | 131.83 | 39.85 | 6.51 | 7.66 |
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7 | 392.77 | 124.39 | 39.17 | 6.87 | 6.53 |
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1 | 342.08 | 152.06 | 39.47 | 6.33 | 5.06 |
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8 | 334.49 | 129.34 | 33.45 | 6.69 | 5.73 |
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4 | 339.87 | 108.73 | 37.76 | 3.26 | 3.26 |
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9 | 460.97 | 106.45 | 39.92 | 5.70 | 5.70 |
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6 | 313.20 | 133.26 | 18.37 | 7.38 | 4.52 |
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2 | 348.51 | 123.89 | 22.01 | 6.91 | 3.58 |
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5 | 326.07 | 129.93 | 38.73 | 7.50 | 0.00 |
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1 | 310.18 | 110.81 | 29.12 | 4.26 | 2.84 |
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6 | 339.95 | 149.45 | 42.70 | 4.93 | 3.28 |
CD8+ T Cells, donor1.CNhs10854.11226-116C2 | 396.96 | 168.34 | 43.55 | 8.87 | 13.51 |
CD8+ T Cells, donor2.CNhs11956.11307-117C2 | 295.79 | 167.42 | 42.26 | 7.49 | 13.91 |
CD8+ T Cells, donor3.CNhs11999.11383-118B6 | 282.26 | 135.27 | 32.30 | 6.23 | 12.02 |
Cardiac Myocyte, donor1.CNhs12341.11525-119I4 | 882.58 | 143.85 | 53.64 | 4.88 | 9.75 |
Cardiac Myocyte, donor2.CNhs12350.11605-120I3 | 619.73 | 112.01 | 47.62 | 22.80 | 9.39 |
Cardiac Myocyte, donor3.CNhs12571.11686-122I3 | 493.04 | 110.60 | 43.60 | 18.28 | 7.42 |
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1 | 461.56 | 92.17 | 27.11 | 12.65 | 8.31 |
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6 | 418.62 | 87.23 | 47.63 | 14.54 | 5.01 |
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6 | 414.99 | 89.08 | 57.07 | 14.92 | 7.24 |
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7 | 343.56 | 120.88 | 35.79 | 18.29 | 10.34 |
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7 | 305.61 | 83.70 | 66.67 | 18.49 | 5.84 |
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9 | 485.81 | 112.59 | 74.40 | 17.77 | 5.77 |
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9 | 402.22 | 101.55 | 66.52 | 20.62 | 7.76 |
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4 | 416.86 | 101.36 | 59.55 | 14.49 | 7.91 |
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1 | 301.45 | 88.74 | 58.81 | 31.76 | 5.44 |
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5 | 89.25 | 36.79 | 15.30 | 7.29 | 3.28 |
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4 | 117.54 | 47.09 | 17.43 | 7.04 | 2.97 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3 | 310.92 | 126.90 | 25.31 | 5.19 | 5.52 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3 | 281.22 | 127.46 | 24.03 | 5.92 | 6.27 |
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7 | 256.87 | 99.59 | 25.26 | 4.52 | 8.11 |
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4 | 246.12 | 151.20 | 33.15 | 5.49 | 8.11 |
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4 | 283.14 | 182.47 | 58.34 | 6.86 | 7.44 |
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8 | 314.62 | 200.22 | 23.40 | 7.43 | 9.29 |
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1 | 296.16 | 98.39 | 29.22 | 8.55 | 5.17 |
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3 | 350.98 | 81.72 | 24.09 | 10.32 | 10.32 |
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8 | 241.61 | 91.65 | 16.66 | 11.11 | 4.17 |
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8 | 231.21 | 109.67 | 27.13 | 9.04 | 6.78 |
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4 | 336.44 | 74.25 | 16.36 | 7.13 | 7.55 |
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9 | 263.01 | 98.22 | 23.39 | 6.88 | 4.68 |
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9 | 301.58 | 80.67 | 27.59 | 8.99 | 6.06 |
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3 | 361.53 | 85.79 | 27.39 | 10.85 | 5.17 |
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3 | 325.17 | 90.72 | 29.53 | 7.83 | 5.69 |
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7 | 299.24 | 107.11 | 19.08 | 10.71 | 4.35 |
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5 | 242.50 | 82.58 | 17.32 | 10.07 | 5.64 |
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1 | 340.60 | 88.19 | 37.25 | 15.97 | 6.08 |
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1 | 159.13 | 59.06 | 20.50 | 8.54 | 3.66 |
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6 | 349.28 | 134.56 | 17.65 | 8.82 | 7.35 |
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2 | 245.47 | 85.88 | 17.82 | 8.91 | 2.43 |
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1 | 349.25 | 123.50 | 32.15 | 10.45 | 4.46 |
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1 | 254.62 | 104.41 | 24.02 | 8.08 | 6.29 |
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5 | 234.46 | 108.90 | 25.79 | 9.23 | 6.53 |
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7 | 360.29 | 84.32 | 23.00 | 1.53 | 6.13 |
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3 | 291.42 | 117.71 | 24.68 | 17.09 | 2.85 |
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3 | 230.65 | 95.63 | 28.40 | 10.63 | 5.13 |
Eosinophils, donor2.CNhs12548.12245-129H4 | 295.19 | 376.89 | 28.99 | 18.45 | 22.40 |
Eosinophils, donor3.CNhs12549.12246-129H5 | 349.00 | 368.39 | 46.53 | 7.76 | 27.14 |
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4 | 126.90 | 34.45 | 18.32 | 10.03 | 3.49 |
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3 | 386.64 | 66.10 | 60.13 | 23.36 | 5.96 |
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3 | 514.88 | 115.36 | 51.79 | 14.82 | 7.34 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3 | 379.22 | 73.88 | 25.69 | 6.49 | 5.56 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9 | 296.02 | 79.74 | 14.34 | 8.61 | 4.88 |
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6 | 345.09 | 108.17 | 44.33 | 14.54 | 7.45 |
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8 | 549.46 | 88.03 | 42.05 | 10.09 | 7.29 |
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4 | 224.17 | 87.53 | 23.48 | 21.35 | 6.40 |
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4 | 319.43 | 75.73 | 30.34 | 10.36 | 3.45 |
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3 | 331.75 | 96.16 | 36.10 | 8.40 | 6.54 |
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7 | 327.21 | 98.47 | 30.71 | 11.18 | 6.87 |
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2 | 419.12 | 95.79 | 33.67 | 13.08 | 6.70 |
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7 | 216.90 | 61.91 | 42.23 | 14.98 | 1.82 |
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6 | 429.83 | 108.32 | 101.41 | 16.13 | 3.46 |
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1 | 72.87 | 61.39 | 19.21 | 13.59 | 3.05 |
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9 | 407.99 | 102.39 | 47.14 | 19.67 | 9.05 |
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5 | 347.99 | 99.26 | 32.52 | 18.26 | 6.85 |
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5 | 307.86 | 90.42 | 56.19 | 17.78 | 5.38 |
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1 | 252.25 | 114.50 | 36.05 | 20.55 | 5.17 |
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5 | 270.65 | 117.36 | 26.87 | 17.48 | 7.28 |
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9 | 288.49 | 114.75 | 33.57 | 21.77 | 7.30 |
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4 | 407.70 | 93.91 | 43.69 | 15.11 | 2.86 |
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4 | 303.03 | 108.59 | 57.61 | 17.07 | 6.14 |
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8 | 259.35 | 89.79 | 44.33 | 11.47 | 4.24 |
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7 | 383.72 | 72.47 | 40.39 | 11.88 | 1.19 |
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7 | 255.67 | 83.08 | 46.24 | 18.05 | 4.95 |
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3 | 67.35 | 48.24 | 9.10 | 5.46 | 0.91 |
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2 | 53.90 | 28.03 | 14.37 | 12.94 | 0.72 |
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5 | 323.54 | 121.71 | 48.48 | 23.57 | 5.22 |
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5 | 217.96 | 118.49 | 39.66 | 12.64 | 5.38 |
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9 | 257.12 | 97.53 | 23.27 | 13.02 | 7.76 |
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8 | 312.99 | 97.89 | 36.87 | 18.88 | 6.58 |
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8 | 408.55 | 90.72 | 57.62 | 15.32 | 1.53 |
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3 | 212.74 | 84.58 | 43.27 | 12.92 | 4.81 |
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8 | 574.42 | 133.40 | 53.99 | 14.07 | 8.96 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9 | 309.45 | 111.40 | 14.53 | 10.05 | 6.10 |
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8 | 408.75 | 100.59 | 60.22 | 21.78 | 5.34 |
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9 | 443.36 | 95.37 | 65.70 | 22.04 | 5.72 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6 | 344.50 | 103.83 | 14.70 | 6.90 | 5.10 |
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3 | 488.37 | 108.10 | 38.44 | 20.40 | 8.35 |
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3 | 394.19 | 93.27 | 23.70 | 11.59 | 3.86 |
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5 | 466.97 | 90.08 | 53.23 | 27.17 | 6.14 |
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9 | 238.99 | 90.13 | 23.29 | 5.57 | 6.41 |
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4 | 452.50 | 131.64 | 37.32 | 18.22 | 8.87 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6 | 382.18 | 101.73 | 18.18 | 10.85 | 5.30 |
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7 | 440.37 | 94.90 | 67.29 | 22.18 | 4.51 |
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1 | 439.84 | 103.13 | 34.75 | 16.00 | 4.20 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3 | 359.62 | 90.17 | 18.46 | 12.78 | 7.46 |
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2 | 481.29 | 131.48 | 43.93 | 21.86 | 9.67 |
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6 | 401.35 | 128.87 | 36.29 | 24.59 | 6.61 |
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6 | 464.99 | 126.59 | 30.92 | 11.79 | 7.54 |
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6 | 404.21 | 131.74 | 33.82 | 10.91 | 11.46 |
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2 | 401.24 | 123.61 | 22.08 | 7.74 | 9.75 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6 | 339.82 | 126.24 | 50.50 | 13.66 | 8.66 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5 | 354.78 | 146.71 | 52.88 | 14.45 | 10.20 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8 | 420.74 | 125.02 | 52.64 | 12.67 | 9.06 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7 | 341.04 | 109.47 | 41.98 | 12.85 | 9.12 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6 | 323.48 | 117.58 | 44.91 | 17.41 | 8.58 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9 | 331.76 | 132.12 | 36.50 | 16.06 | 9.12 |
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2 | 508.46 | 48.50 | 40.68 | 15.64 | 9.39 |
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7 | 280.45 | 84.26 | 24.44 | 11.58 | 1.93 |
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7 | 266.60 | 62.16 | 34.53 | 16.58 | 6.91 |
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1 | 555.85 | 80.34 | 55.26 | 18.11 | 5.11 |
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9 | 747.15 | 83.74 | 75.08 | 19.49 | 6.50 |
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8 | 390.89 | 114.17 | 26.15 | 11.48 | 6.86 |
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9 | 389.94 | 138.07 | 30.01 | 12.64 | 6.74 |
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1 | 362.00 | 139.55 | 23.38 | 10.36 | 7.95 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9 | 400.37 | 116.03 | 32.21 | 9.93 | 5.18 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1 | 355.80 | 133.12 | 26.80 | 11.11 | 6.75 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2 | 361.36 | 125.99 | 24.68 | 13.29 | 7.83 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4 | 426.07 | 105.44 | 34.38 | 12.54 | 4.99 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5 | 450.72 | 111.85 | 32.77 | 10.01 | 5.89 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6 | 418.22 | 113.89 | 30.78 | 10.00 | 3.85 |
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9 | 132.87 | 42.07 | 11.07 | 11.07 | 0.74 |
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8 | 58.90 | 39.27 | 7.01 | 7.01 | 1.40 |
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3 | 142.82 | 34.16 | 13.17 | 10.70 | 2.88 |
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2 | 108.79 | 26.46 | 13.23 | 7.35 | 2.94 |
Hepatocyte, donor1.CNhs12340.11523-119I2 | 352.38 | 77.32 | 26.62 | 7.61 | 2.54 |
Hepatocyte, donor2.CNhs12349.11603-120I1 | 296.81 | 85.51 | 26.54 | 6.88 | 4.91 |
Hepatocyte, donor3.CNhs12626.11684-122I1 | 337.93 | 85.66 | 30.72 | 10.04 | 3.54 |
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3 | 319.62 | 111.69 | 14.13 | 2.21 | 4.86 |
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4 | 415.45 | 114.38 | 15.00 | 5.66 | 6.03 |
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9 | 473.53 | 104.83 | 52.33 | 16.13 | 6.52 |
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3 | 263.51 | 116.23 | 21.73 | 6.69 | 6.48 |
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8 | 273.14 | 101.16 | 40.46 | 8.99 | 6.74 |
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8 | 278.77 | 128.68 | 40.21 | 10.96 | 5.63 |
Keratinocyte - oral, donor1.CNhs10879.11251-116E9 | 354.61 | 120.46 | 49.44 | 13.43 | 7.78 |
Keratocytes, donor1.CNhs11337.11527-119I6 | 125.76 | 72.66 | 28.67 | 17.27 | 5.21 |
Keratocytes, donor2.CNhs12095.11607-120I5 | 81.11 | 32.24 | 12.48 | 8.32 | 3.12 |
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8 | 581.66 | 129.90 | 34.64 | 7.22 | 8.66 |
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7 | 375.73 | 94.95 | 68.98 | 19.82 | 6.96 |
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7 | 584.93 | 110.60 | 44.15 | 11.04 | 10.33 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1 | 355.57 | 102.79 | 43.17 | 14.29 | 5.63 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6 | 308.81 | 74.54 | 37.96 | 13.43 | 2.78 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2 | 390.78 | 81.81 | 30.06 | 9.13 | 2.47 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1 | 379.30 | 98.78 | 18.17 | 7.90 | 7.11 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4 | 517.67 | 111.60 | 20.60 | 8.58 | 7.73 |
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8 | 252.86 | 103.41 | 45.06 | 11.33 | 4.68 |
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8 | 331.35 | 104.37 | 37.67 | 7.25 | 9.13 |
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3 | 214.77 | 91.41 | 36.41 | 6.99 | 4.31 |
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9 | 679.57 | 148.10 | 63.74 | 22.50 | 14.06 |
Mallassez-derived cells, donor2.CNhs13550.11929-125I3 | 345.20 | 138.08 | 54.26 | 14.11 | 8.57 |
Mallassez-derived cells, donor3.CNhs13551.11930-125I4 | 495.08 | 151.13 | 40.55 | 14.74 | 9.36 |
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4 | 187.18 | 158.07 | 26.51 | 11.28 | 11.28 |
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9 | 265.93 | 178.45 | 29.64 | 11.63 | 13.08 |
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9 | 188.24 | 65.18 | 25.30 | 8.43 | 7.28 |
Mast cell - stimulated, donor1.CNhs11073.11487-119E2 | 255.20 | 256.68 | 51.24 | 1.97 | 17.74 |
Mast cell, donor1.CNhs12566.11563-120D6 | 265.47 | 97.56 | 37.16 | 7.92 | 5.90 |
Mast cell, donor2.CNhs12594.11565-120D8 | 196.34 | 153.63 | 37.94 | 13.27 | 5.81 |
Mast cell, donor3.CNhs12593.11566-120D9 | 159.11 | 141.09 | 41.79 | 18.59 | 6.77 |
Mast cell, donor4.CNhs12592.11567-120E1 | 178.00 | 123.47 | 30.30 | 13.76 | 6.44 |
Melanocyte - dark, donor3.CNhs12570.11663-122F7 | 312.60 | 91.88 | 32.64 | 8.06 | 6.92 |
Melanocyte - light, donor1.CNhs11303.11274-116H5 | 141.34 | 69.14 | 16.81 | 8.02 | 5.35 |
Melanocyte - light, donor2.CNhs11383.11351-117H1 | 220.37 | 60.95 | 23.44 | 3.52 | 3.52 |
Melanocyte - light, donor3.CNhs12033.11423-118G1 | 201.87 | 58.16 | 23.95 | 3.42 | 3.42 |
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4 | 252.75 | 86.48 | 36.30 | 9.97 | 4.42 |
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3 | 315.96 | 76.89 | 32.14 | 9.01 | 4.51 |
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2 | 334.70 | 74.03 | 36.01 | 6.29 | 3.14 |
Meningeal Cells, donor1.CNhs11320.11493-119E8 | 165.62 | 74.01 | 25.01 | 12.90 | 3.03 |
Meningeal Cells, donor2.CNhs12080.11573-120E7 | 199.23 | 54.93 | 15.26 | 8.72 | 5.23 |
Meningeal Cells, donor3.CNhs12731.11654-122E7 | 356.86 | 145.36 | 63.73 | 18.26 | 5.28 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9 | 472.62 | 94.63 | 39.17 | 11.12 | 4.65 |
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7 | 92.99 | 14.31 | 17.88 | 3.58 | 0.00 |
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6 | 303.46 | 135.25 | 43.11 | 15.22 | 10.14 |
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8 | 478.95 | 98.13 | 43.35 | 18.62 | 3.46 |
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7 | 397.31 | 84.25 | 39.52 | 16.64 | 5.20 |
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6 | 177.73 | 47.58 | 25.72 | 13.63 | 2.31 |
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5 | 90.78 | 45.39 | 14.18 | 11.35 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5 | 133.48 | 35.43 | 22.91 | 13.85 | 1.60 |
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7 | 430.79 | 109.09 | 85.93 | 22.02 | 4.86 |
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9 | 151.93 | 54.26 | 23.88 | 16.28 | 5.97 |
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8 | 212.40 | 37.05 | 39.52 | 21.40 | 1.65 |
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2 | 385.67 | 128.01 | 51.79 | 15.31 | 7.49 |
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3 | 439.98 | 107.33 | 62.90 | 20.97 | 5.33 |
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8 | 497.35 | 144.14 | 38.81 | 16.63 | 7.92 |
Mesothelial Cells, donor1.CNhs10850.11247-116E5 | 747.27 | 82.90 | 38.28 | 14.17 | 6.93 |
Mesothelial Cells, donor2.CNhs12197.12156-128G5 | 817.50 | 95.00 | 52.29 | 11.33 | 10.46 |
Mesothelial Cells, donor3.CNhs12012.11402-118D7 | 472.17 | 107.47 | 29.79 | 9.70 | 8.10 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5 | 221.36 | 70.54 | 31.62 | 8.51 | 1.22 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2 | 209.44 | 80.86 | 27.62 | 7.03 | 1.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8 | 225.59 | 99.09 | 33.73 | 6.33 | 6.33 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1 | 457.68 | 121.49 | 39.30 | 13.90 | 10.78 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9 | 349.18 | 101.08 | 50.54 | 12.63 | 3.45 |
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4 | 181.15 | 115.54 | 22.82 | 7.13 | 9.98 |
Myoblast, donor1.CNhs10870.11241-116D8 | 496.74 | 106.56 | 53.71 | 10.57 | 8.69 |
Myoblast, donor2.CNhs11965.11322-117D8 | 407.67 | 94.93 | 46.64 | 8.01 | 4.93 |
Myoblast, donor3.CNhs11908.11398-118D3 | 448.55 | 113.52 | 42.80 | 11.28 | 9.67 |
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3 | 230.33 | 108.61 | 18.27 | 3.59 | 4.82 |
Natural Killer Cells, donor1.CNhs10859.11230-116C6 | 342.64 | 162.94 | 40.79 | 5.32 | 11.43 |
Natural Killer Cells, donor2.CNhs11957.11311-117C6 | 268.03 | 143.18 | 43.99 | 9.06 | 9.49 |
Natural Killer Cells, donor3.CNhs12001.11387-118C1 | 259.77 | 140.54 | 41.45 | 5.78 | 12.32 |
Neural stem cells, donor1.CNhs11063.11275-116H6 | 333.63 | 175.07 | 71.15 | 22.36 | 7.62 |
Neural stem cells, donor2.CNhs11384.11352-117H2 | 261.58 | 190.00 | 58.56 | 18.22 | 15.62 |
Neurons, donor1.CNhs12338.11494-119E9 | 565.27 | 156.98 | 88.93 | 32.48 | 12.37 |
Neurons, donor2.CNhs12726.11574-120E8 | 458.83 | 164.67 | 106.37 | 23.95 | 6.87 |
Neurons, donor3.CNhs13815.11655-122E8 | 545.44 | 108.45 | 112.28 | 31.26 | 5.74 |
Neutrophils, donor1.CNhs10862.11233-116C9 | 298.85 | 229.20 | 38.95 | 28.46 | 10.49 |
Neutrophils, donor2.CNhs11959.11314-117C9 | 290.19 | 278.22 | 56.84 | 5.98 | 2.99 |
Neutrophils, donor3.CNhs11905.11390-118C4 | 260.25 | 272.69 | 27.77 | 13.68 | 19.48 |
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1 | 453.35 | 104.17 | 78.65 | 17.91 | 4.05 |
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5 | 510.17 | 100.53 | 53.52 | 17.51 | 3.50 |
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4 | 447.32 | 107.15 | 36.35 | 20.62 | 3.80 |
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7 | 330.26 | 53.66 | 61.14 | 12.89 | 3.12 |
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8 | 439.11 | 58.88 | 71.01 | 19.45 | 2.50 |
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9 | 375.80 | 60.40 | 57.40 | 16.72 | 2.21 |
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1 | 330.92 | 68.76 | 55.29 | 15.58 | 2.23 |
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7 | 384.31 | 67.11 | 60.79 | 22.87 | 4.21 |
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3 | 320.64 | 88.69 | 20.47 | 13.64 | 6.82 |
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3 | 212.12 | 52.77 | 42.42 | 14.49 | 4.14 |
Osteoblast, donor2.CNhs11385.11354-117H4 | 452.34 | 154.76 | 56.46 | 20.59 | 7.97 |
Osteoblast, donor3.CNhs12036.11426-118G4 | 194.88 | 93.84 | 31.34 | 13.83 | 9.59 |
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7 | 452.58 | 94.79 | 58.91 | 16.42 | 5.30 |
Pericytes, donor1.CNhs11317.11491-119E6 | 84.98 | 31.72 | 23.69 | 10.96 | 1.57 |
Pericytes, donor2.CNhs12079.11571-120E5 | 109.81 | 30.20 | 10.64 | 8.24 | 1.72 |
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7 | 236.96 | 152.18 | 28.95 | 6.00 | 2.89 |
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7 | 211.18 | 149.71 | 40.77 | 8.20 | 8.41 |
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2 | 199.79 | 149.42 | 32.23 | 6.62 | 9.18 |
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9 | 296.46 | 124.89 | 14.55 | 7.58 | 6.06 |
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5 | 379.47 | 86.55 | 28.29 | 16.64 | 3.33 |
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5 | 216.51 | 68.64 | 24.49 | 8.47 | 4.54 |
Preadipocyte - breast, donor1.CNhs11052.11467-119B9 | 430.22 | 105.69 | 60.04 | 28.78 | 3.72 |
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9 | 366.93 | 87.93 | 40.67 | 8.29 | 5.99 |
Preadipocyte - breast, donor2.CNhs11971.11328-117E5 | 348.02 | 83.64 | 49.68 | 17.12 | 5.33 |
Preadipocyte - omental, donor1.CNhs11065.11468-119C1 | 501.66 | 106.10 | 52.92 | 17.56 | 3.46 |
Preadipocyte - omental, donor2.CNhs11902.11329-117E6 | 507.61 | 101.83 | 56.80 | 21.49 | 6.14 |
Preadipocyte - omental, donor3.CNhs12013.11403-118D8 | 370.29 | 79.62 | 43.91 | 13.35 | 4.66 |
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2 | 516.49 | 78.66 | 32.65 | 13.36 | 5.94 |
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6 | 247.04 | 127.84 | 42.87 | 19.12 | 9.10 |
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6 | 355.12 | 94.11 | 60.19 | 20.60 | 9.23 |
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2 | 368.01 | 119.66 | 46.07 | 16.34 | 4.68 |
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7 | 333.88 | 128.26 | 58.68 | 18.69 | 7.79 |
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7 | 383.03 | 84.60 | 40.09 | 18.48 | 6.62 |
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2 | 403.67 | 145.15 | 18.25 | 5.44 | 7.98 |
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8 | 430.69 | 114.69 | 25.46 | 7.82 | 11.03 |
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9 | 368.51 | 106.35 | 29.74 | 9.94 | 9.85 |
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3 | 514.71 | 128.48 | 49.37 | 14.24 | 8.73 |
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9 | 354.17 | 116.17 | 35.14 | 14.02 | 9.47 |
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1 | 512.57 | 88.64 | 52.84 | 17.70 | 4.98 |
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4 | 125.43 | 36.10 | 25.72 | 11.28 | 4.06 |
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3 | 414.65 | 128.62 | 62.77 | 22.03 | 8.78 |
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5 | 61.96 | 26.67 | 14.12 | 12.55 | 2.35 |
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4 | 74.53 | 32.15 | 14.61 | 13.15 | 0.00 |
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4 | 390.22 | 118.01 | 64.28 | 18.58 | 7.39 |
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2 | 69.38 | 26.16 | 9.10 | 4.55 | 3.41 |
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1 | 177.92 | 54.60 | 14.63 | 9.19 | 2.72 |
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1 | 348.92 | 135.81 | 27.42 | 9.28 | 10.36 |
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1 | 60.15 | 24.68 | 15.42 | 3.08 | 4.63 |
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6 | 136.29 | 33.60 | 17.34 | 10.57 | 3.25 |
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5 | 87.29 | 22.58 | 16.05 | 9.03 | 1.00 |
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3 | 186.82 | 58.11 | 25.23 | 16.82 | 2.04 |
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2 | 151.26 | 56.51 | 21.61 | 4.99 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2 | 120.67 | 36.27 | 23.95 | 8.28 | 2.91 |
Reticulocytes, biol_rep1.CNhs13552.11931-125I5 | 526.44 | 144.71 | 38.59 | 19.95 | 6.80 |
Reticulocytes, biol_rep2.CNhs13553.11932-125I6 | 538.56 | 130.72 | 45.23 | 18.30 | 6.80 |
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9 | 427.76 | 162.85 | 48.73 | 12.82 | 9.49 |
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7 | 265.69 | 48.87 | 30.18 | 11.15 | 3.61 |
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6 | 283.73 | 199.78 | 60.20 | 18.22 | 6.18 |
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5 | 315.00 | 101.91 | 32.56 | 10.92 | 6.59 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6 | 230.85 | 90.10 | 30.58 | 7.97 | 3.57 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5 | 270.14 | 131.03 | 38.53 | 7.92 | 6.19 |
Sebocyte, donor1.CNhs10847.11220-116B5 | 215.35 | 101.07 | 22.40 | 6.89 | 6.32 |
Sebocyte, donor2.CNhs11951.11301-117B5 | 229.47 | 97.51 | 33.15 | 5.20 | 7.80 |
Sertoli Cells, donor1.CNhs10851.11255-116F4 | 531.86 | 86.77 | 46.60 | 16.07 | 8.03 |
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3 | 196.05 | 98.31 | 51.43 | 22.04 | 4.16 |
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2 | 335.06 | 105.68 | 38.36 | 19.26 | 8.16 |
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6 | 315.45 | 97.17 | 32.70 | 18.73 | 9.21 |
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1 | 308.06 | 112.61 | 33.49 | 19.43 | 6.20 |
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7 | 360.93 | 95.17 | 67.25 | 18.69 | 4.40 |
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7 | 205.05 | 89.48 | 54.53 | 22.77 | 5.37 |
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2 | 263.69 | 116.33 | 41.16 | 12.53 | 10.23 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4 | 320.16 | 97.04 | 47.10 | 18.43 | 4.63 |
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5 | 416.02 | 139.00 | 40.16 | 12.23 | 8.59 |
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2 | 222.56 | 103.59 | 19.60 | 4.04 | 7.69 |
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6 | 162.58 | 65.59 | 7.02 | 3.96 | 4.85 |
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2 | 220.02 | 107.13 | 18.31 | 6.98 | 9.41 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2 | 797.21 | 145.96 | 43.70 | 42.30 | 7.44 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3 | 342.83 | 84.05 | 19.52 | 9.13 | 5.67 |
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4 | 281.60 | 57.85 | 41.13 | 13.94 | 3.49 |
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5 | 335.45 | 77.01 | 33.58 | 10.47 | 5.54 |
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1 | 432.23 | 61.22 | 34.60 | 17.57 | 6.92 |
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1 | 269.68 | 84.38 | 40.89 | 15.66 | 6.96 |
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6 | 555.42 | 72.83 | 56.89 | 18.72 | 4.82 |
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2 | 307.00 | 101.90 | 23.62 | 13.17 | 9.16 |
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1 | 396.35 | 94.90 | 64.01 | 18.24 | 5.21 |
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1 | 449.89 | 108.20 | 49.36 | 15.19 | 7.28 |
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5 | 364.10 | 92.84 | 42.51 | 11.44 | 8.39 |
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9 | 98.52 | 35.83 | 15.35 | 15.10 | 3.07 |
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8 | 358.61 | 184.87 | 30.81 | 14.98 | 6.85 |
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7 | 354.48 | 61.10 | 49.00 | 19.09 | 3.82 |
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3 | 398.75 | 86.34 | 34.54 | 21.98 | 4.71 |
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6 | 377.73 | 110.80 | 57.92 | 18.89 | 3.96 |
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6 | 370.90 | 107.07 | 44.47 | 12.90 | 3.57 |
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1 | 340.24 | 103.67 | 40.17 | 13.31 | 6.01 |
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8 | 411.85 | 59.24 | 32.75 | 13.14 | 4.45 |
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4 | 459.68 | 55.48 | 36.46 | 9.51 | 4.76 |
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4 | 407.36 | 88.89 | 32.02 | 14.74 | 4.63 |
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5 | 102.40 | 35.60 | 15.60 | 9.27 | 2.93 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5 | 371.91 | 94.56 | 34.36 | 10.48 | 9.02 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5 | 459.58 | 54.94 | 17.96 | 22.19 | 5.28 |
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6 | 463.14 | 110.02 | 29.76 | 19.52 | 9.01 |
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3 | 366.66 | 88.10 | 44.97 | 11.74 | 5.37 |
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6 | 326.59 | 62.15 | 41.81 | 21.47 | 7.91 |
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2 | 392.02 | 59.00 | 41.90 | 15.99 | 4.96 |
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7 | 502.22 | 78.29 | 50.42 | 12.61 | 6.63 |
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7 | 523.51 | 76.29 | 34.20 | 22.36 | 6.58 |
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1 | 209.52 | 32.41 | 26.62 | 15.63 | 1.74 |
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9 | 327.29 | 89.20 | 54.44 | 28.20 | 1.97 |
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3 | 379.24 | 69.19 | 48.09 | 22.73 | 7.10 |
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8 | 278.84 | 85.20 | 41.52 | 12.70 | 8.98 |
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8 | 358.04 | 63.10 | 31.27 | 14.93 | 6.48 |
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2 | 458.06 | 116.02 | 52.92 | 22.23 | 11.04 |
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1 | 365.78 | 104.73 | 51.97 | 19.06 | 9.04 |
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6 | 379.14 | 69.19 | 49.58 | 22.11 | 4.64 |
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8 | 485.67 | 101.11 | 52.86 | 21.64 | 11.71 |
Synoviocyte, donor2.CNhs11992.11368-117I9 | 415.25 | 78.74 | 78.53 | 14.99 | 6.76 |
Synoviocyte, donor3.CNhs12050.11440-118H9 | 479.45 | 61.25 | 51.04 | 18.77 | 4.28 |
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2 | 120.29 | 48.57 | 23.91 | 16.70 | 3.04 |
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1 | 95.53 | 47.94 | 15.75 | 12.25 | 3.15 |
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5 | 324.85 | 106.61 | 35.99 | 13.37 | 4.71 |
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1 | 241.31 | 75.74 | 25.47 | 10.05 | 6.03 |
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1 | 223.23 | 87.11 | 21.78 | 7.62 | 7.62 |
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4 | 306.72 | 98.19 | 33.42 | 12.71 | 6.68 |
Urothelial Cells, donor1.CNhs11334.11520-119H8 | 136.47 | 37.45 | 14.21 | 9.04 | 3.01 |
Urothelial Cells, donor2.CNhs12091.11600-120H7 | 144.89 | 47.17 | 28.64 | 11.79 | 1.68 |
Urothelial Cells, donor3.CNhs12122.11681-122H7 | 100.66 | 36.80 | 16.85 | 10.20 | 2.66 |
Urothelial cells, donor0.CNhs10843.11216-116B1 | 314.72 | 93.73 | 48.01 | 14.24 | 4.36 |
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1 | 1220.41 | 134.47 | 46.18 | 38.57 | 5.07 |
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2 | 1189.01 | 116.22 | 35.17 | 27.53 | 3.82 |
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3 | 786.68 | 88.86 | 63.80 | 23.93 | 2.85 |
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7 | 509.10 | 106.01 | 38.83 | 18.34 | 1.67 |
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8 | 429.46 | 110.66 | 44.43 | 23.04 | 2.06 |
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4 | 1050.53 | 123.86 | 27.24 | 30.48 | 1.95 |
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5 | 1106.52 | 129.07 | 39.42 | 29.16 | 2.70 |
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6 | 862.13 | 92.00 | 57.90 | 32.52 | 3.17 |
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8 | 289.39 | 117.51 | 31.62 | 8.55 | 5.77 |
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3 | 94.32 | 82.77 | 17.32 | 3.85 | 5.77 |
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6 | 243.32 | 66.16 | 46.80 | 18.87 | 3.92 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5 | 376.81 | 91.60 | 21.55 | 8.73 | 7.25 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3 | 232.85 | 118.01 | 17.60 | 5.63 | 5.48 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6 | 327.39 | 122.79 | 10.17 | 3.20 | 6.40 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5 | 420.73 | 136.63 | 21.52 | 4.62 | 9.57 |
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8 | 124.94 | 58.48 | 34.93 | 7.98 | 1.80 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6 | 207.21 | 56.88 | 17.04 | 4.60 | 2.30 |
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9 | 121.92 | 63.08 | 15.24 | 4.23 | 1.27 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5 | 264.24 | 90.89 | 20.78 | 5.52 | 2.27 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9 | 398.73 | 92.10 | 32.57 | 8.99 | 2.81 |
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9 | 184.87 | 70.98 | 21.91 | 5.71 | 5.48 |
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1 | 196.63 | 138.51 | 28.52 | 11.44 | 4.23 |
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2 | 233.09 | 100.25 | 12.53 | 7.52 | 2.51 |
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3 | 299.99 | 115.96 | 37.07 | 10.67 | 4.06 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4 | 283.76 | 99.40 | 56.37 | 15.90 | 3.21 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5 | 259.72 | 115.63 | 43.79 | 11.70 | 2.22 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8 | 165.65 | 132.86 | 16.61 | 8.94 | 4.26 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5 | 230.84 | 121.94 | 42.94 | 11.68 | 3.09 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3 | 347.49 | 141.64 | 33.49 | 8.91 | 2.77 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4 | 342.00 | 159.70 | 31.76 | 12.30 | 4.92 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9 | 331.70 | 163.68 | 33.70 | 9.84 | 5.01 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6 | 203.99 | 102.19 | 17.98 | 7.42 | 2.93 |
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7 | 245.83 | 120.55 | 20.05 | 9.47 | 3.62 |
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8 | 220.33 | 132.93 | 41.85 | 11.08 | 2.46 |
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9 | 133.06 | 63.02 | 18.39 | 5.68 | 2.98 |
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6 | 176.86 | 123.90 | 27.31 | 6.66 | 4.00 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1 | 177.64 | 91.64 | 23.97 | 4.23 | 2.82 |
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4 | 212.22 | 78.60 | 24.52 | 4.87 | 4.68 |
adipose tissue, adult, pool1.CNhs10615.10010-101C1 | 252.43 | 96.11 | 37.80 | 21.39 | 3.37 |
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9 | 194.66 | 79.49 | 29.61 | 8.86 | 4.13 |
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7 | 189.23 | 122.36 | 51.15 | 13.60 | 4.01 |
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6 | 445.81 | 116.50 | 76.72 | 17.62 | 4.26 |
amniotic membrane cells, donor1.CNhs12502.12235-129G3 | 484.17 | 104.33 | 68.04 | 25.78 | 11.94 |
amniotic membrane cells, donor2.CNhs12503.12236-129G4 | 440.40 | 117.89 | 42.47 | 18.11 | 10.69 |
amniotic membrane cells, donor3.CNhs12379.12237-129G5 | 635.52 | 103.21 | 62.97 | 27.34 | 10.75 |
amygdala - adult, donor10196.CNhs13793.10167-103B5 | 772.45 | 179.94 | 126.26 | 40.76 | 7.95 |
amygdala, adult, donor10252.CNhs12311.10151-102I7 | 416.38 | 100.58 | 89.33 | 16.04 | 9.57 |
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5 | 334.59 | 102.63 | 29.16 | 12.02 | 3.56 |
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3 | 254.79 | 117.34 | 50.43 | 17.47 | 8.90 |
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4 | 260.53 | 101.13 | 34.20 | 6.33 | 8.23 |
aorta, adult, pool1.CNhs11760.10052-101G7 | 317.60 | 65.55 | 85.48 | 23.71 | 2.39 |
appendix, adult.CNhs12842.10189-103D9 | 190.64 | 79.29 | 22.38 | 6.08 | 4.97 |
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4 | 346.66 | 118.41 | 45.10 | 8.31 | 7.05 |
astrocytoma cell line:TM-31.CNhs10742.10425-106D2 | 232.25 | 87.75 | 34.16 | 14.22 | 4.70 |
b cell line:RPMI1788.CNhs10744.10427-106D4 | 211.34 | 121.48 | 30.03 | 7.88 | 6.65 |
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9 | 537.17 | 98.29 | 72.16 | 29.86 | 10.89 |
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9 | 312.83 | 147.65 | 17.52 | 8.09 | 8.36 |
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1 | 357.33 | 197.82 | 10.92 | 4.30 | 7.16 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7 | 135.57 | 88.50 | 14.84 | 10.23 | 4.09 |
bladder, adult, pool1.CNhs10616.10011-101C2 | 332.23 | 92.63 | 77.93 | 29.10 | 4.04 |
blood, adult, pool1.CNhs11761.10053-101G8 | 577.15 | 55.08 | 79.03 | 23.95 | 4.79 |
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2 | 322.30 | 125.58 | 31.12 | 6.67 | 5.56 |
brain, adult, donor1.CNhs11796.10084-102B3 | 453.65 | 133.77 | 114.38 | 40.71 | 14.54 |
brain, adult, pool1.CNhs10617.10012-101C3 | 647.71 | 172.73 | 185.35 | 42.67 | 12.06 |
brain, fetal, pool1.CNhs11797.10085-102B4 | 281.46 | 115.78 | 85.83 | 33.93 | 7.98 |
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5 | 340.64 | 120.58 | 22.14 | 5.47 | 6.51 |
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5 | 302.35 | 94.54 | 27.81 | 7.61 | 3.15 |
breast, adult, donor1.CNhs11792.10080-102A8 | 261.00 | 58.00 | 29.72 | 8.70 | 3.62 |
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4 | 317.48 | 89.21 | 10.47 | 4.67 | 2.96 |
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7 | 259.85 | 81.11 | 34.07 | 10.42 | 2.54 |
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8 | 432.59 | 129.07 | 35.22 | 11.35 | 4.96 |
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1 | 174.10 | 65.85 | 34.82 | 13.10 | 3.45 |
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8 | 243.49 | 162.72 | 31.78 | 7.00 | 11.08 |
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3 | 234.22 | 140.64 | 46.53 | 9.38 | 3.99 |
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6 | 679.36 | 117.80 | 68.20 | 29.23 | 2.66 |
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2 | 412.68 | 93.70 | 77.06 | 15.80 | 10.37 |
cerebellum - adult, donor10196.CNhs13799.10173-103C2 | 401.29 | 117.49 | 122.07 | 36.62 | 6.10 |
cerebellum, adult, donor10252.CNhs12323.10166-103B4 | 296.68 | 110.14 | 91.56 | 20.79 | 8.85 |
cerebellum, adult, pool1.CNhs11795.10083-102B2 | 409.63 | 119.70 | 151.91 | 38.13 | 11.23 |
cerebral meninges, adult.CNhs12840.10188-103D8 | 485.50 | 173.97 | 165.20 | 23.47 | 9.65 |
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3 | 240.54 | 118.53 | 40.20 | 13.94 | 6.32 |
cervical cancer cell line:ME-180.CNhs11289.10553-107I4 | 435.70 | 219.73 | 15.75 | 6.69 | 23.56 |
cervix, adult, pool1.CNhs10618.10013-101C4 | 274.25 | 88.11 | 52.63 | 19.55 | 5.62 |
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5 | 580.76 | 150.40 | 34.87 | 10.37 | 8.77 |
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6 | 102.37 | 80.47 | 5.30 | 1.84 | 5.53 |
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9 | 411.81 | 147.20 | 32.94 | 12.39 | 7.36 |
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2 | 364.40 | 159.49 | 8.91 | 3.80 | 8.37 |
chorionic membrane cells, donor1.CNhs12504.12238-129G6 | 504.34 | 100.17 | 63.16 | 21.05 | 6.38 |
chorionic membrane cells, donor2.CNhs12506.12239-129G7 | 377.93 | 118.62 | 37.10 | 11.17 | 9.80 |
chorionic membrane cells, donor3.CNhs12380.12240-129G8 | 539.43 | 108.21 | 57.03 | 23.45 | 9.59 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2 | 463.96 | 197.23 | 22.48 | 7.15 | 2.04 |
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9 | 320.08 | 75.98 | 49.76 | 10.52 | 2.83 |
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1 | 213.08 | 69.48 | 29.42 | 8.14 | 1.99 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5 | 261.92 | 131.30 | 39.70 | 15.79 | 4.06 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6 | 249.98 | 106.85 | 34.90 | 12.94 | 4.31 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7 | 235.62 | 129.05 | 33.40 | 10.24 | 5.03 |
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4 | 323.91 | 114.61 | 41.18 | 21.63 | 3.23 |
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4 | 239.68 | 78.51 | 35.76 | 7.31 | 4.61 |
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8 | 402.37 | 106.34 | 82.50 | 26.37 | 3.16 |
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6 | 587.31 | 169.11 | 38.69 | 13.22 | 9.14 |
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9 | 430.84 | 158.32 | 24.60 | 8.91 | 10.32 |
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6 | 202.32 | 88.50 | 31.59 | 11.47 | 2.60 |
colon, adult, donor1.CNhs11794.10082-102B1 | 233.89 | 52.75 | 18.91 | 7.96 | 2.99 |
colon, adult, pool1.CNhs10619.10014-101C5 | 284.30 | 86.16 | 29.10 | 10.26 | 3.36 |
colon, fetal, donor1.CNhs11780.10070-101I7 | 251.74 | 54.99 | 29.33 | 10.39 | 1.83 |
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2 | 221.80 | 176.73 | 11.86 | 5.93 | 9.79 |
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3 | 287.04 | 159.77 | 14.95 | 5.93 | 8.40 |
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8 | 308.98 | 147.13 | 20.15 | 5.95 | 8.46 |
corpus callosum, adult, pool1.CNhs10649.10042-101F6 | 387.76 | 111.01 | 67.74 | 24.80 | 6.40 |
diaphragm, fetal, donor1.CNhs11779.10069-101I6 | 337.08 | 74.64 | 28.89 | 12.04 | 4.82 |
diencephalon, adult.CNhs12610.10193-103E4 | 648.68 | 176.40 | 102.84 | 29.75 | 13.59 |
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1 | 271.13 | 101.99 | 42.88 | 11.49 | 4.38 |
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6 | 293.11 | 161.23 | 27.78 | 18.39 | 3.13 |
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2 | 266.82 | 103.91 | 33.75 | 12.38 | 7.04 |
ductus deferens, adult.CNhs12846.10196-103E7 | 298.70 | 64.32 | 41.43 | 11.44 | 1.58 |
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8 | 241.98 | 61.71 | 20.57 | 4.84 | 2.42 |
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9 | 287.71 | 111.10 | 74.07 | 17.45 | 6.73 |
dura mater, adult, donor1.CNhs10648.10041-101F5 | 235.50 | 92.25 | 50.36 | 19.08 | 3.48 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1 | 179.19 | 129.58 | 14.43 | 3.91 | 14.28 |
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9 | 275.08 | 121.32 | 33.39 | 12.96 | 9.85 |
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1 | 123.63 | 109.00 | 17.95 | 4.65 | 3.32 |
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2 | 195.29 | 102.28 | 38.73 | 9.27 | 4.63 |
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3 | 164.50 | 132.79 | 27.94 | 5.02 | 5.02 |
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9 | 193.55 | 99.16 | 19.12 | 3.58 | 4.78 |
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2 | 236.23 | 99.61 | 24.19 | 7.40 | 4.27 |
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7 | 272.91 | 111.63 | 61.43 | 24.82 | 3.61 |
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4 | 666.12 | 107.09 | 42.00 | 5.90 | 7.12 |
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3 | 258.90 | 118.67 | 22.73 | 6.08 | 8.43 |
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8 | 195.36 | 94.29 | 11.84 | 3.48 | 7.92 |
epididymis, adult.CNhs12847.10197-103E8 | 311.01 | 65.35 | 40.71 | 16.42 | 2.27 |
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2 | 232.01 | 85.48 | 49.70 | 19.78 | 2.24 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5 | 463.85 | 123.46 | 16.84 | 6.10 | 7.55 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6 | 336.28 | 113.65 | 14.33 | 4.75 | 6.29 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7 | 400.64 | 122.27 | 18.31 | 5.99 | 8.46 |
esophagus, adult, pool1.CNhs10620.10015-101C6 | 356.14 | 117.74 | 47.33 | 16.20 | 7.76 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5 | 160.54 | 93.29 | 35.04 | 10.24 | 2.65 |
eye, fetal, donor1.CNhs11762.10054-101G9 | 383.94 | 87.23 | 70.28 | 18.53 | 6.55 |
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2 | 282.44 | 90.04 | 37.41 | 15.49 | 5.34 |
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9 | 337.02 | 164.54 | 45.70 | 13.31 | 8.94 |
frontal lobe, adult, pool1.CNhs10647.10040-101F4 | 484.96 | 168.03 | 145.23 | 34.25 | 14.69 |
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2 | 299.58 | 91.13 | 15.45 | 4.89 | 8.02 |
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1 | 265.33 | 105.17 | 62.12 | 19.80 | 3.13 |
gall bladder, adult.CNhs12848.10198-103E9 | 280.05 | 62.76 | 41.62 | 12.81 | 3.63 |
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2 | 588.24 | 195.01 | 16.78 | 4.40 | 19.38 |
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9 | 239.33 | 129.68 | 19.31 | 6.92 | 6.77 |
gastric cancer cell line:AZ521.CNhs11286.10549-107H9 | 208.46 | 141.11 | 24.51 | 9.28 | 8.82 |
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3 | 241.95 | 100.90 | 21.28 | 5.83 | 6.69 |
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1 | 316.78 | 288.97 | 82.11 | 31.40 | 15.70 |
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1 | 386.67 | 123.51 | 32.31 | 10.69 | 5.34 |
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4 | 266.57 | 136.23 | 15.79 | 4.71 | 6.60 |
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3 | 386.38 | 113.48 | 41.72 | 16.17 | 6.25 |
glioblastoma cell line:A172.CNhs11185.10444-106F3 | 411.30 | 130.54 | 45.61 | 17.78 | 5.23 |
glioblastoma cell line:T98G.CNhs11272.10485-107A8 | 524.98 | 140.76 | 50.90 | 19.18 | 8.06 |
glioma cell line:GI-1.CNhs10731.10413-106B8 | 225.38 | 76.57 | 35.54 | 10.11 | 4.05 |
globus pallidus - adult, donor10196.CNhs13801.10175-103C4 | 553.59 | 89.46 | 94.27 | 24.62 | 6.60 |
globus pallidus, adult, donor10252.CNhs12319.10161-103A8 | 321.86 | 78.86 | 55.45 | 16.15 | 5.34 |
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7 | 26.83 | 393.46 | 6.39 | 1.28 | 16.61 |
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3 | 375.61 | 119.05 | 49.85 | 11.60 | 5.59 |
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1 | 325.98 | 98.85 | 23.13 | 6.05 | 6.57 |
heart - mitral valve, adult.CNhs12855.10205-103F7 | 351.06 | 105.85 | 51.95 | 17.87 | 7.26 |
heart - pulmonic valve, adult.CNhs12856.10206-103F8 | 311.66 | 102.89 | 49.73 | 15.81 | 2.52 |
heart - tricuspid valve, adult.CNhs12857.10207-103F9 | 228.28 | 102.66 | 36.61 | 8.61 | 5.03 |
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5 | 359.42 | 87.66 | 41.53 | 11.38 | 9.19 |
heart, adult, diseased, donor1.CNhs11758.10051-101G6 | 585.46 | 109.02 | 66.10 | 17.17 | 6.01 |
heart, adult, pool1.CNhs10621.10016-101C7 | 425.59 | 151.76 | 38.16 | 15.85 | 10.27 |
heart, fetal, pool1.CNhs10653.10046-101G1 | 332.09 | 134.37 | 45.89 | 14.58 | 7.05 |
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4 | 348.77 | 63.41 | 54.77 | 18.01 | 4.32 |
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3 | 209.69 | 122.32 | 13.98 | 0.00 | 4.66 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8 | 242.81 | 95.96 | 14.97 | 3.15 | 8.59 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9 | 242.47 | 103.93 | 17.06 | 3.54 | 7.83 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1 | 247.91 | 96.86 | 16.04 | 4.99 | 7.48 |
hepatoma cell line:Li-7.CNhs11271.10484-107A7 | 423.83 | 187.01 | 45.38 | 20.87 | 10.04 |
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7 | 225.32 | 144.71 | 20.83 | 5.59 | 6.77 |
hippocampus - adult, donor10196.CNhs13795.10169-103B7 | 762.63 | 104.18 | 143.94 | 29.42 | 5.57 |
hippocampus, adult, donor10252.CNhs12312.10153-102I9 | 392.40 | 89.21 | 85.40 | 18.66 | 6.13 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5 | 310.25 | 112.37 | 44.21 | 16.08 | 5.14 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4 | 345.22 | 98.62 | 35.62 | 11.14 | 7.98 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8 | 464.05 | 98.46 | 41.54 | 9.56 | 4.99 |
immature langerhans cells, donor1.CNhs13537.11904-125F5 | 243.65 | 285.72 | 57.59 | 11.25 | 13.50 |
immature langerhans cells, donor2.CNhs13480.11905-125F6 | 263.87 | 144.70 | 48.75 | 8.51 | 10.83 |
insula, adult, pool1.CNhs10646.10039-101F3 | 455.26 | 167.49 | 143.13 | 35.23 | 13.55 |
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8 | 266.67 | 68.76 | 20.13 | 6.04 | 3.02 |
kidney, adult, pool1.CNhs10622.10017-101C8 | 422.24 | 104.50 | 42.71 | 13.40 | 3.63 |
kidney, fetal, pool1.CNhs10652.10045-101F9 | 291.33 | 85.19 | 32.63 | 12.85 | 5.19 |
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5 | 384.91 | 142.67 | 39.28 | 12.46 | 7.92 |
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2 | 354.63 | 121.92 | 39.62 | 11.47 | 4.30 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8 | 240.47 | 108.62 | 15.55 | 6.33 | 8.25 |
left atrium, adult, donor1.CNhs11790.10079-102A7 | 502.43 | 84.33 | 93.63 | 22.87 | 2.86 |
left ventricle, adult, donor1.CNhs11789.10078-102A6 | 630.31 | 89.38 | 68.20 | 21.19 | 5.96 |
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1 | 170.11 | 90.77 | 41.95 | 9.66 | 4.83 |
leiomyoma cell line:10964C.CNhs11722.10569-108B2 | 746.62 | 77.11 | 70.59 | 21.72 | 2.17 |
leiomyoma cell line:15242A.CNhs11723.10570-108B3 | 957.56 | 83.83 | 70.87 | 25.06 | 6.91 |
leiomyoma cell line:15425.CNhs11724.10571-108B4 | 696.28 | 95.69 | 79.03 | 27.11 | 6.53 |
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8 | 259.81 | 171.21 | 57.47 | 20.35 | 10.78 |
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5 | 197.02 | 122.73 | 69.53 | 10.34 | 8.13 |
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8 | 452.04 | 75.31 | 46.86 | 14.14 | 4.43 |
liposarcoma cell line:SW 872.CNhs11851.10726-110A6 | 389.91 | 171.33 | 91.33 | 29.01 | 10.42 |
liver, adult, pool1.CNhs10624.10018-101C9 | 319.04 | 92.47 | 32.83 | 10.55 | 5.28 |
liver, fetal, pool1.CNhs11798.10086-102B5 | 323.32 | 71.55 | 33.13 | 14.58 | 5.30 |
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2 | 659.47 | 104.33 | 88.43 | 21.98 | 6.72 |
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3 | 503.15 | 96.66 | 67.31 | 17.32 | 8.33 |
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4 | 314.97 | 132.08 | 26.52 | 10.27 | 3.59 |
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3 | 234.00 | 83.87 | 20.44 | 11.98 | 3.52 |
lung, adult, pool1.CNhs10625.10019-101D1 | 271.24 | 108.92 | 41.01 | 12.92 | 4.81 |
lung, fetal, donor1.CNhs11680.10068-101I5 | 371.32 | 133.78 | 32.70 | 14.93 | 4.09 |
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3 | 228.25 | 57.16 | 30.65 | 14.08 | 3.31 |
lymph node, adult, donor1.CNhs11788.10077-102A5 | 212.86 | 76.91 | 36.22 | 11.41 | 1.49 |
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7 | 153.74 | 79.24 | 20.35 | 4.94 | 5.53 |
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1 | 638.44 | 260.15 | 41.53 | 9.13 | 13.03 |
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7 | 273.85 | 222.78 | 15.32 | 3.19 | 10.21 |
mature adipocyte, donor1.CNhs12558.12231-129F8 | 319.34 | 140.90 | 44.61 | 14.69 | 7.62 |
mature adipocyte, donor2.CNhs12559.12232-129F9 | 470.54 | 132.61 | 46.88 | 17.80 | 9.02 |
mature adipocyte, donor3.CNhs12560.12233-129G1 | 481.27 | 138.16 | 72.60 | 21.44 | 7.96 |
mature adipocyte, donor4.CNhs12562.12234-129G2 | 445.91 | 147.54 | 62.95 | 20.00 | 7.54 |
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9 | 277.67 | 66.75 | 28.90 | 7.85 | 1.73 |
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8 | 764.68 | 157.72 | 153.29 | 49.62 | 12.40 |
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3 | 778.65 | 159.85 | 287.13 | 39.78 | 8.42 |
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6 | 440.05 | 103.16 | 105.79 | 21.53 | 10.14 |
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3 | 758.05 | 92.89 | 80.85 | 29.82 | 4.59 |
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2 | 447.16 | 94.73 | 65.00 | 13.53 | 6.54 |
medulla oblongata, adult, pool1.CNhs10645.10038-101F2 | 483.23 | 122.39 | 74.39 | 25.09 | 7.45 |
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1 | 261.20 | 101.13 | 43.16 | 11.62 | 5.95 |
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3 | 227.34 | 108.73 | 32.24 | 11.62 | 6.75 |
melanoma cell line:COLO 679.CNhs11281.10514-107E1 | 204.27 | 105.24 | 20.93 | 6.22 | 11.98 |
melanoma cell line:G-361.CNhs11254.10465-106H6 | 186.98 | 89.07 | 43.11 | 14.56 | 2.57 |
meningioma cell line:HKBMM.CNhs11945.10691-109F7 | 286.08 | 99.99 | 87.05 | 24.70 | 4.47 |
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6 | 200.45 | 111.93 | 34.19 | 13.11 | 7.49 |
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7 | 132.17 | 54.20 | 21.30 | 4.20 | 2.90 |
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1 | 428.81 | 102.69 | 49.25 | 14.48 | 8.36 |
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2 | 319.25 | 96.29 | 46.28 | 16.36 | 9.58 |
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3 | 554.25 | 119.28 | 22.19 | 12.76 | 5.55 |
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4 | 520.86 | 93.00 | 50.38 | 16.86 | 8.90 |
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5 | 451.31 | 83.77 | 53.84 | 15.09 | 10.57 |
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4 | 479.61 | 83.64 | 50.72 | 15.13 | 4.45 |
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6 | 517.64 | 90.16 | 46.23 | 14.65 | 10.76 |
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7 | 368.40 | 98.91 | 35.54 | 12.25 | 8.77 |
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8 | 451.86 | 110.98 | 45.23 | 15.39 | 9.17 |
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9 | 539.23 | 110.45 | 36.52 | 13.01 | 11.98 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1 | 497.96 | 112.94 | 31.38 | 10.67 | 10.35 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6 | 331.50 | 78.72 | 36.88 | 16.19 | 1.80 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5 | 404.77 | 96.42 | 38.97 | 13.04 | 6.37 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9 | 402.27 | 87.92 | 34.84 | 12.86 | 5.39 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3 | 612.50 | 79.75 | 60.35 | 19.41 | 6.65 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8 | 301.57 | 76.70 | 36.52 | 17.22 | 4.70 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7 | 454.83 | 78.58 | 48.83 | 23.29 | 7.06 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2 | 544.17 | 84.92 | 31.99 | 15.61 | 5.33 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2 | 696.16 | 155.83 | 39.87 | 18.72 | 13.83 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4 | 418.98 | 107.29 | 43.46 | 16.18 | 8.18 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6 | 432.65 | 114.07 | 45.97 | 19.55 | 8.06 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6 | 263.11 | 83.06 | 64.96 | 22.74 | 2.78 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1 | 394.51 | 84.00 | 39.41 | 13.54 | 6.77 |
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1 | 546.04 | 164.41 | 81.21 | 18.80 | 9.20 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8 | 498.95 | 81.73 | 52.20 | 14.08 | 4.46 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9 | 362.68 | 84.19 | 47.48 | 18.52 | 3.37 |
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3 | 282.65 | 123.66 | 25.24 | 7.57 | 5.05 |
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7 | 212.46 | 128.48 | 53.55 | 20.61 | 4.62 |
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8 | 409.37 | 98.43 | 28.31 | 13.30 | 6.43 |
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4 | 353.39 | 137.80 | 36.02 | 17.49 | 5.22 |
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5 | 541.15 | 160.28 | 56.90 | 30.15 | 5.21 |
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6 | 607.05 | 151.42 | 48.85 | 15.28 | 9.72 |
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7 | 437.59 | 211.94 | 35.98 | 12.97 | 12.48 |
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8 | 565.38 | 157.78 | 30.98 | 9.49 | 9.31 |
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9 | 313.74 | 161.19 | 42.61 | 17.60 | 9.88 |
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1 | 396.68 | 111.40 | 27.19 | 8.77 | 1.97 |
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1 | 381.47 | 152.48 | 25.44 | 14.84 | 8.66 |
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9 | 359.40 | 159.73 | 33.37 | 14.47 | 9.45 |
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2 | 521.02 | 134.99 | 43.93 | 18.75 | 4.05 |
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8 | 494.03 | 173.48 | 86.61 | 33.82 | 3.33 |
mesothelioma cell line:No36.CNhs13074.10857-111G2 | 376.52 | 114.34 | 29.36 | 10.71 | 4.84 |
mesothelioma cell line:ONE58.CNhs13075.10858-111G3 | 477.36 | 175.63 | 24.61 | 11.55 | 13.07 |
middle temporal gyrus, donor10252.CNhs12316.10156-103A3 | 412.29 | 98.30 | 106.74 | 17.70 | 7.88 |
migratory langerhans cells, donor1.CNhs13535.11901-125F2 | 488.13 | 175.96 | 71.51 | 15.39 | 4.29 |
migratory langerhans cells, donor2.CNhs13536.11902-125F3 | 281.67 | 166.21 | 37.07 | 7.97 | 4.38 |
migratory langerhans cells, donor3.CNhs13547.11903-125F4 | 330.57 | 180.25 | 44.00 | 9.81 | 8.18 |
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5 | 366.60 | 141.86 | 61.92 | 19.33 | 14.74 |
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9 | 238.15 | 87.50 | 219.23 | 50.38 | 9.83 |
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1 | 171.37 | 185.32 | 16.06 | 5.49 | 15.43 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6 | 175.99 | 102.59 | 33.00 | 7.60 | 5.40 |
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7 | 232.16 | 115.01 | 23.37 | 7.15 | 3.84 |
myeloma cell line:PCM6.CNhs11258.10474-106I6 | 195.81 | 100.92 | 18.94 | 6.20 | 6.54 |
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6 | 157.77 | 107.83 | 39.16 | 11.92 | 5.68 |
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9 | 233.26 | 74.56 | 43.82 | 11.97 | 7.00 |
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3 | 341.31 | 121.42 | 46.30 | 18.46 | 13.85 |
nasal epithelial cells, donor2.CNhs12574.12227-129F4 | 228.92 | 113.22 | 24.88 | 9.95 | 20.53 |
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4 | 216.27 | 122.91 | 30.82 | 7.93 | 5.12 |
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8 | 312.58 | 110.41 | 82.05 | 20.38 | 8.52 |
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4 | 286.38 | 108.04 | 39.00 | 10.85 | 5.50 |
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6 | 230.87 | 115.54 | 39.21 | 10.16 | 7.32 |
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9 | 166.34 | 52.11 | 26.82 | 5.09 | 2.38 |
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7 | 298.03 | 71.43 | 41.66 | 6.80 | 2.76 |
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6 | 313.31 | 75.60 | 34.70 | 6.82 | 3.97 |
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8 | 149.72 | 110.61 | 22.90 | 7.26 | 8.94 |
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9 | 316.10 | 76.64 | 56.29 | 14.63 | 7.31 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7 | 228.30 | 117.90 | 28.94 | 7.02 | 3.39 |
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1 | 426.70 | 93.67 | 76.85 | 31.22 | 8.81 |
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3 | 484.93 | 80.76 | 64.89 | 20.10 | 7.76 |
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2 | 432.42 | 108.41 | 78.71 | 25.11 | 3.98 |
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1 | 428.34 | 152.74 | 109.13 | 33.21 | 14.07 |
occipital cortex - adult, donor10196.CNhs13798.10172-103C1 | 695.73 | 151.62 | 121.86 | 39.68 | 9.92 |
occipital cortex, adult, donor10252.CNhs12320.10163-103B1 | 331.56 | 83.33 | 71.68 | 16.28 | 9.10 |
occipital lobe, adult, donor1.CNhs11787.10076-102A4 | 479.56 | 162.04 | 140.71 | 31.79 | 10.46 |
occipital lobe, fetal, donor1.CNhs11784.10073-102A1 | 306.52 | 101.84 | 89.23 | 24.45 | 6.81 |
occipital pole, adult, pool1.CNhs10643.10036-101E9 | 435.83 | 152.98 | 134.10 | 41.15 | 12.93 |
olfactory region, adult.CNhs12611.10195-103E6 | 566.13 | 144.04 | 181.01 | 32.62 | 10.98 |
optic nerve, donor1.CNhs13449.10277-104E7 | 415.46 | 118.50 | 47.11 | 12.85 | 4.28 |
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2 | 226.92 | 77.83 | 13.25 | 4.12 | 4.32 |
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1 | 268.74 | 94.38 | 31.14 | 8.85 | 4.01 |
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5 | 338.43 | 134.45 | 33.57 | 6.24 | 8.07 |
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4 | 263.98 | 186.11 | 23.80 | 10.97 | 11.09 |
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2 | 285.27 | 116.32 | 49.96 | 10.30 | 4.96 |
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6 | 82.15 | 121.50 | 11.74 | 5.52 | 6.90 |
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9 | 306.33 | 78.77 | 25.46 | 9.35 | 3.98 |
ovary, adult, pool1.CNhs10626.10020-101D2 | 304.68 | 87.70 | 42.79 | 28.05 | 3.91 |
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3 | 168.22 | 56.88 | 27.03 | 5.45 | 3.83 |
pancreas, adult, donor1.CNhs11756.10049-101G4 | 202.41 | 57.05 | 28.13 | 12.50 | 1.56 |
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5 | 328.43 | 126.76 | 14.67 | 5.50 | 5.50 |
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5 | 374.38 | 112.84 | 30.46 | 6.88 | 5.08 |
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3 | 259.78 | 98.32 | 16.41 | 4.58 | 5.47 |
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8 | 473.57 | 179.51 | 131.36 | 34.11 | 16.75 |
parietal lobe - adult, donor10196.CNhs13797.10171-103B9 | 672.51 | 124.97 | 137.47 | 31.24 | 11.72 |
parietal lobe, adult, donor10252.CNhs12317.10157-103A4 | 454.09 | 115.74 | 116.78 | 19.43 | 9.51 |
parietal lobe, adult, pool1.CNhs10641.10034-101E7 | 463.38 | 159.93 | 115.04 | 31.58 | 15.66 |
parietal lobe, fetal, donor1.CNhs11782.10072-101I9 | 339.12 | 111.58 | 90.80 | 22.97 | 6.56 |
parotid gland, adult.CNhs12849.10199-103F1 | 271.39 | 58.66 | 27.96 | 20.83 | 2.19 |
penis, adult.CNhs12850.10200-103F2 | 336.93 | 78.90 | 60.04 | 23.82 | 2.48 |
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4 | 187.83 | 75.80 | 62.43 | 16.53 | 2.11 |
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3 | 283.63 | 99.78 | 23.12 | 6.26 | 5.37 |
pineal gland - adult, donor10196.CNhs13804.10179-103C8 | 569.99 | 102.32 | 71.78 | 17.68 | 8.04 |
pineal gland, adult, donor10252.CNhs12228.10160-103A7 | 393.45 | 111.98 | 87.10 | 24.88 | 8.41 |
pituitary gland - adult, donor10196.CNhs13805.10180-103C9 | 576.62 | 75.26 | 62.52 | 22.46 | 1.82 |
pituitary gland, adult, donor10252.CNhs12229.10162-103A9 | 430.74 | 80.14 | 55.78 | 18.44 | 7.29 |
placenta, adult, pool1.CNhs10627.10021-101D3 | 402.09 | 147.69 | 50.38 | 14.46 | 9.23 |
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3 | 215.26 | 125.95 | 20.74 | 4.84 | 5.42 |
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4 | 421.35 | 117.13 | 46.64 | 18.69 | 7.37 |
pons, adult, pool1.CNhs10640.10033-101E6 | 570.47 | 175.50 | 103.11 | 30.38 | 16.79 |
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5 | 493.10 | 159.83 | 149.50 | 37.75 | 13.94 |
prostate cancer cell line:DU145.CNhs11260.10490-107B4 | 346.78 | 132.73 | 30.02 | 13.59 | 6.38 |
prostate cancer cell line:PC-3.CNhs11243.10439-106E7 | 260.06 | 68.18 | 28.25 | 11.46 | 2.89 |
prostate, adult, pool1.CNhs10628.10022-101D4 | 345.13 | 90.27 | 53.92 | 26.45 | 3.85 |
putamen, adult, donor10196.CNhs12324.10176-103C5 | 555.56 | 126.48 | 124.59 | 21.21 | 11.63 |
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1 | 336.05 | 91.93 | 8.97 | 3.92 | 8.97 |
rectum, fetal, donor1.CNhs11777.10067-101I4 | 199.07 | 71.23 | 36.53 | 9.13 | 7.31 |
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6 | 326.27 | 123.51 | 73.85 | 33.68 | 3.67 |
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3 | 238.40 | 62.59 | 111.32 | 33.92 | 1.91 |
retina, adult, pool1.CNhs10636.10030-101E3 | 384.83 | 76.77 | 58.61 | 23.52 | 3.57 |
retinoblastoma cell line:Y79.CNhs11267.10475-106I7 | 186.46 | 100.02 | 44.09 | 14.06 | 5.37 |
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4 | 239.81 | 110.89 | 35.10 | 6.63 | 5.35 |
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9 | 120.66 | 106.92 | 23.12 | 12.00 | 5.22 |
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2 | 230.09 | 100.21 | 29.66 | 8.02 | 5.61 |
salivary acinar cells, donor1.CNhs12810.11771-123I7 | 399.31 | 95.94 | 34.61 | 7.25 | 5.39 |
salivary acinar cells, donor2.CNhs12811.11772-123I8 | 366.53 | 106.70 | 27.83 | 8.37 | 5.29 |
salivary acinar cells, donor3.CNhs12812.11773-123I9 | 209.45 | 103.69 | 13.83 | 2.77 | 10.37 |
salivary gland, adult, pool1.CNhs11677.10093-102C3 | 326.97 | 83.46 | 11.62 | 14.20 | 0.43 |
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1 | 198.44 | 132.53 | 56.80 | 14.08 | 5.68 |
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1 | 175.71 | 163.87 | 56.84 | 13.38 | 3.41 |
seminal vesicle, adult.CNhs12851.10201-103F3 | 268.43 | 70.71 | 53.77 | 15.24 | 0.85 |
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9 | 453.86 | 86.60 | 38.95 | 12.60 | 7.79 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7 | 478.65 | 133.08 | 43.43 | 28.54 | 7.44 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5 | 514.08 | 109.89 | 59.24 | 24.84 | 7.64 |
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9 | 334.67 | 97.87 | 20.02 | 3.58 | 4.25 |
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4 | 217.11 | 161.85 | 14.33 | 5.20 | 8.05 |
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6 | 348.93 | 120.45 | 14.39 | 4.39 | 7.19 |
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3 | 486.87 | 124.95 | 27.84 | 14.89 | 9.71 |
skeletal muscle, adult, pool1.CNhs10629.10023-101D5 | 542.16 | 109.44 | 51.64 | 15.81 | 8.21 |
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3 | 308.51 | 49.87 | 27.84 | 16.24 | 1.16 |
skin, fetal, donor1.CNhs11774.10065-101I2 | 305.03 | 77.71 | 51.49 | 9.71 | 3.89 |
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8 | 298.51 | 85.15 | 16.84 | 9.12 | 6.78 |
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7 | 151.80 | 50.53 | 25.86 | 6.57 | 3.38 |
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4 | 268.64 | 128.67 | 47.09 | 14.03 | 6.30 |
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1 | 438.12 | 154.62 | 23.27 | 11.63 | 6.78 |
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5 | 146.66 | 72.78 | 34.41 | 13.85 | 2.64 |
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4 | 209.99 | 83.78 | 19.63 | 5.74 | 4.83 |
small intestine, adult, pool1.CNhs10630.10024-101D6 | 299.36 | 95.46 | 18.52 | 7.79 | 4.86 |
small intestine, fetal, donor1.CNhs11773.10064-101I1 | 348.17 | 76.71 | 38.90 | 8.52 | 3.28 |
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6 | 209.76 | 86.07 | 31.98 | 11.29 | 4.70 |
smooth muscle, adult, pool1.CNhs11755.10048-101G3 | 348.85 | 78.94 | 76.73 | 27.21 | 3.92 |
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7 | 119.96 | 109.35 | 41.01 | 10.37 | 6.60 |
spinal cord - adult, donor10196.CNhs13807.10181-103D1 | 716.33 | 85.59 | 112.48 | 21.59 | 4.71 |
spinal cord, adult, donor10252.CNhs12227.10159-103A6 | 509.73 | 93.57 | 76.04 | 24.36 | 8.02 |
spinal cord, fetal, donor1.CNhs11764.10056-101H2 | 310.23 | 132.29 | 71.01 | 17.33 | 9.30 |
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8 | 203.40 | 86.49 | 37.55 | 11.39 | 6.29 |
spleen, adult, pool1.CNhs10631.10025-101D7 | 200.19 | 111.09 | 31.11 | 10.06 | 4.79 |
spleen, fetal, pool1.CNhs10651.10044-101F8 | 190.86 | 94.69 | 24.43 | 7.28 | 4.83 |
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1 | 197.18 | 112.63 | 19.89 | 6.00 | 5.10 |
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4 | 193.91 | 94.99 | 22.68 | 6.43 | 2.86 |
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4 | 196.56 | 130.22 | 19.41 | 4.59 | 12.35 |
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9 | 439.24 | 178.94 | 28.16 | 13.64 | 9.31 |
stomach, fetal, donor1.CNhs11771.10062-101H8 | 150.45 | 98.60 | 21.18 | 6.57 | 4.38 |
submaxillary gland, adult.CNhs12852.10202-103F4 | 251.38 | 72.02 | 23.40 | 14.22 | 4.13 |
substantia nigra, adult, donor10252.CNhs12318.10158-103A5 | 433.46 | 85.29 | 68.09 | 16.77 | 5.16 |
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9 | 236.18 | 75.57 | 26.35 | 5.52 | 5.52 |
temporal lobe, adult, pool1.CNhs10637.10031-101E4 | 428.14 | 151.82 | 141.15 | 35.15 | 11.08 |
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9 | 243.05 | 89.45 | 90.76 | 15.71 | 6.11 |
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8 | 295.20 | 100.52 | 34.92 | 10.58 | 3.17 |
tenocyte, donor1.CNhs12639.11763-123H8 | 345.96 | 92.63 | 51.34 | 14.88 | 5.21 |
tenocyte, donor2.CNhs12640.11765-123I1 | 496.84 | 86.89 | 73.49 | 18.49 | 7.86 |
tenocyte, donor3.CNhs12641.11768-123I4 | 427.87 | 97.34 | 70.09 | 21.63 | 5.62 |
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6 | 305.20 | 90.46 | 49.20 | 14.64 | 6.94 |
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7 | 428.87 | 152.64 | 43.16 | 12.89 | 8.63 |
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6 | 248.33 | 76.53 | 29.39 | 10.01 | 4.94 |
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3 | 297.20 | 73.53 | 23.87 | 8.16 | 6.94 |
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6 | 248.24 | 92.46 | 17.10 | 5.08 | 4.54 |
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8 | 333.39 | 112.76 | 19.94 | 7.54 | 9.56 |
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5 | 367.29 | 49.39 | 17.05 | 5.26 | 1.75 |
testis, adult, pool1.CNhs10632.10026-101D8 | 391.25 | 85.86 | 62.14 | 43.72 | 5.30 |
testis, adult, pool2.CNhs12998.10096-102C6 | 321.29 | 86.82 | 71.81 | 76.91 | 5.09 |
thalamus - adult, donor10196.CNhs13794.10168-103B6 | 640.95 | 127.69 | 116.08 | 26.53 | 4.98 |
thalamus, adult, donor10252.CNhs12314.10154-103A1 | 416.83 | 92.47 | 68.68 | 16.65 | 6.83 |
throat, adult.CNhs12858.10209-103G2 | 340.96 | 78.90 | 36.46 | 10.24 | 4.69 |
throat, fetal, donor1.CNhs11770.10061-101H7 | 292.82 | 74.99 | 30.95 | 8.33 | 4.29 |
thymus, adult, pool1.CNhs10633.10027-101D9 | 273.40 | 138.67 | 13.11 | 3.49 | 9.17 |
thymus, fetal, pool1.CNhs10650.10043-101F7 | 287.16 | 118.38 | 13.78 | 3.35 | 7.95 |
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9 | 210.81 | 80.96 | 54.16 | 23.10 | 5.27 |
thyroid, adult, pool1.CNhs10634.10028-101E1 | 521.91 | 113.86 | 33.73 | 13.30 | 6.36 |
thyroid, fetal, donor1.CNhs11769.10060-101H6 | 300.35 | 88.12 | 30.72 | 8.69 | 7.07 |
tongue, adult.CNhs12853.10203-103F5 | 444.58 | 112.34 | 42.67 | 10.89 | 6.31 |
tongue, fetal, donor1.CNhs11768.10059-101H5 | 475.70 | 97.88 | 47.91 | 13.00 | 5.82 |
tonsil, adult, pool1.CNhs10654.10047-101G2 | 221.52 | 99.75 | 23.17 | 8.55 | 6.53 |
trachea, adult, pool1.CNhs10635.10029-101E2 | 327.41 | 103.14 | 37.22 | 13.99 | 4.59 |
trachea, fetal, donor1.CNhs11766.10058-101H4 | 270.79 | 70.86 | 29.94 | 5.99 | 2.99 |
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4 | 272.05 | 129.19 | 19.46 | 6.35 | 7.24 |
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6 | 160.52 | 83.25 | 27.00 | 10.25 | 4.48 |
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1 | 204.66 | 79.16 | 23.17 | 9.65 | 7.72 |
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5 | 342.41 | 92.25 | 25.60 | 7.90 | 4.31 |
umbilical cord, fetal, donor1.CNhs11765.10057-101H3 | 328.50 | 75.09 | 39.89 | 14.08 | 4.69 |
uterus, adult, pool1.CNhs11676.10100-102D1 | 294.24 | 120.53 | 33.74 | 21.15 | 4.52 |
uterus, fetal, donor1.CNhs11763.10055-101H1 | 299.48 | 76.50 | 42.32 | 8.95 | 5.70 |
vagina, adult.CNhs12854.10204-103F6 | 235.01 | 87.88 | 23.30 | 16.64 | 4.66 |
vein, adult.CNhs12844.10191-103E2 | 211.94 | 88.96 | 29.79 | 8.25 | 1.01 |
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5 | 294.92 | 107.39 | 23.72 | 5.45 | 5.13 |